sree Chitra Tirunal Institute for Medical sciences and Technology
Department of Neurology
Dr P N Sylaja, MD (Medicine), DM (Neurology), FRCP Edin is the Professor and Head of Neurology and Head of the Comprehensive Stroke Care Program at Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, Kerala ,India . She has been working in stroke for the past 22 years. She is the past President of the Indian Stroke Association, Honorary Professor of the University of Lanchashire , UK , fellow of the European Stroke Organization and fellow of the Indian Academy of Neurology . She is the member of the Task Force Group of the Non-communicable disease division of the Indian Council of Medical Research. She is technical consultant for the stroke care for the Government of Kerala. She has been working with the government in starting primary stroke units in the district hospitals in her state and actively involved in training nurses and community health workers in stroke care for the past 7 years. She was the international scientific committee cochair of the Asia pacific stroke conference 2021 and the scientific committee member of the World Stroke Congress 2022 . She is a member of the guideline committee of the World Stroke Organization. She is the national CME convenor for the Indian Academy of Neurology and associate editor of the Cerebrovascular diseases journal and Journal of Stroke medicine. She is the PI of many stroke trials and had received funding from DBT-NIH,ICMR and NIHR. She has 180 publications to her credit .

Moderator of 3 Sessions

Session Type
Clinical Manifestations
Date
Thu, 27.10.2022
Session Time
08:00 - 09:30
Room
Summit 2
Session Type
Other
Date
Fri, 28.10.2022
Session Time
17:15 - 18:45
Room
Summit 1
Session Type
Other
Date
Sat, 29.10.2022
Session Time
09:40 - 11:10
Room
Nicoll 2-3

Presenter of 12 Presentations

Opening by Chairs

Session Type
Clinical Manifestations
Date
Thu, 27.10.2022
Session Time
08:00 - 09:30
Room
Summit 2
Lecture Time
08:00 - 08:02

Closing by Chairs

Session Type
Other
Date
Fri, 28.10.2022
Session Time
17:15 - 18:45
Room
Summit 1
Lecture Time
18:33 - 18:38

Opening by Chairs

Session Type
Other
Date
Sat, 29.10.2022
Session Time
09:40 - 11:10
Room
Nicoll 2-3
Lecture Time
09:40 - 09:45

Conclusion for No

Session Type
Prevention
Date
Thu, 27.10.2022
Session Time
10:00 - 11:30
Room
Summit 1
Presenter
Lecture Time
11:16 - 11:18

The Fine Art of PACNS Treatment: From Easy to Tough Cases

Session Type
Clinical Manifestations
Date
Fri, 28.10.2022
Session Time
08:00 - 09:30
Room
Room 324-325
Presenter
Lecture Time
09:05 - 09:25

Opening by Chairs

Session Type
Other
Date
Fri, 28.10.2022
Session Time
17:15 - 18:45
Room
Summit 1
Lecture Time
17:15 - 17:17

Closing by Chairs

Session Type
Clinical Manifestations
Date
Thu, 27.10.2022
Session Time
08:00 - 09:30
Room
Summit 2
Lecture Time
09:25 - 09:30

Closing by Chairs

Session Type
Other
Date
Sat, 29.10.2022
Session Time
09:40 - 11:10
Room
Nicoll 2-3
Lecture Time
11:02 - 11:07

B) Should Double Antiplatelet Be Given Routine for a Short Period for All Non-AF Ischemic Stroke Patients (DAPT)? - No

Session Type
Prevention
Date
Thu, 27.10.2022
Session Time
10:00 - 11:30
Room
Summit 1
Presenter
Lecture Time
10:52 - 11:04

CAROTID ENDARTERECTOMY FOR SYMPTOMATIC CAROTID STENOSIS-CLINICAL PROFILE AND OUTCOME: A DEVELOPING COUNTRY PERSPECTIVE

Session Name
0850 - SHORT COMMUNICATIONS 04: RISK FACTORS, BIOMARKERS AND PREVENTION 01 (ID 400)
Session Type
E-Poster
Date
Wed, 26.10.2022
Session Time
15:30 - 17:00
Room
GALLERY
Presenter
Lecture Time
15:30 - 15:30

CAROTID ENDARTERECTOMY FOR SYMPTOMATIC CAROTID STENOSIS-CLINICAL PROFILE AND OUTCOME: A DEVELOPING COUNTRY PERSPECTIVE

Session Type
Prevention
Date
Wed, 26.10.2022
Session Time
15:30 - 17:00
Room
Room 332
Presenter
Lecture Time
15:30 - 15:30

Abstract

Background and Aims

Carotid Endarterectomy (CEA) is the standard treatment for patients with symptomatic carotid stenosis. Data from Low- and Middle-Income Countries (LMIC) is sparse on CEA and its outcome. We aimed to describe the clinical profile and predictors of periprocedural events in patients with symptomatic carotid stenosis who underwent CEA at our institute.

Methods

A retrospective review of patients with symptomatic carotid stenosis(50-99%) who underwent CEA between January 2011 and December 2021 was done. The clinical and imaging parameters and their influence on periprocedural events were analyzed.

Results

Of the 319 patients (77% males) with a mean age of 64 years (SD ±8.6), 207 patients(65%) presented with stroke. The majority (85%) had high-grade stenosis of the symptomatic carotid. The mean time to CEA was 50 days (SD ±36), however, only 26 patients (8.2%) underwent surgery within 2 weeks. Minor strokes and TIA occurred in 2.2%, while major strokes and death occurred in 4.1% of patients. None of the clinical or imaging parameters predicted the periprocedural adverse events except the presence of hemodynamic infarcts(12.8% vs 4.8%; P=0.019). The presence of co-existing significant(>50%) tandem intracranial atherosclerosis(24%) and the presence of contralateral carotid occlusion(7.5%) were not predictors of the periprocedural stroke risk(P=0.12 and 0.09 respectively).

Conclusions

There is a delay in patients undergoing CEA for symptomatic carotid stenosis. The majority have high-grade stenosis and present only after a stroke. CEA can be performed safely in patients with significant intracranial tandem stenosis and contralateral carotid occlusion.

Hide

DOES THROMBUS IMAGING CHARACTERISTICS PREDICT THE DEGREE OF RECANALISATION AFTER ENDOVASCULAR THROMBECTOMY IN ACUTE ISCHAEMIC STROKE?

Session Name
0120 - E-Poster Viewing: AS09 Stroke Neuroimaging (ID 420)
Session Type
E-Poster
Date
Wed, 26.10.2022
Session Time
07:00 - 23:59
Room
GALLERY
Presenter
Lecture Time
07:00 - 07:00

Abstract

Background and Aims

Identification of computed tomography (CT) thrombus imaging characteristics can predict the degree of recanalization and outcome after endovascular thrombectomy (EVT) in patients with acute ischaemic stroke and large vessel occlusion.

Aim: We analyzed the thrombus imaging characteristics and procedural factors and correlated with the degree of recanalization and functional outcome after EVT.

Methods

We evaluated the thrombus imaging characteristics (hyperdense MCA sign, thrombus location, length and permeability) from thin slice CT and CT angiogram. In addition, groin to recanalization time, number of passes, and EVT technique were documented. The primary outcome was degree of recanalization (mTICI score) and secondary outcome was modified Rankin scale (mRS) at 3 months.

Results

The mean age of 102 patients was 60.5±11.8 years. Patients with hyperdense MCA sign (90 % vs 75%, p=0.07) and permeable thrombus (86 % vs 70 %, p=0.09) had good recanalization (mTICI grade 2b,2c or 3). The requirement of <3 passes (90 % vs 62 %, p= 0.001) was associated with good recanalization. Multiple logistic regression analysis showed thrombus permeability (OR 5.9; 95% CI 1.3-26.6, p=0.02), use of stent retreiver alone (without aspiration) (OR 5.4; 95% CI 1.3-22.5, p=0.02) and a puncture to recanalization ≤60 minutes (OR 7.9; 95% CI 1.7-36.8; p=0.008) were associated with good recanalization. The requirement of ≥3 passes was associated with poor functional outcome (OR 3.4 ;95% CI 1.2-9.8; p=0.02).

Conclusions

Thrombus permeability was a predictor of successful recanalization after EVT. The requirement of three or more passes during EVT was associated with poor recanalization and poor functional outcome.

Hide